SCHEMBL14488281

SCHEMBL14488281

Nc1ccnn1-c1cncnc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.59
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 2/20 0.36
PKM P14618 2/20 0.36
CYP2A6 P11509 2/20 0.32
MEN1 O00255 1/20 0.31
MAPT P10636 1/20 0.31
ALOX15 P16050 1/20 0.31
KMT2A Q03164 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
CA4 P22748 1/20 0.30
CA7 P43166 1/20 0.30
SCN9A Q15858 1/20 0.30
GRM1 Q13255 1/20 0.30
CYP17A1 P05093 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP11B1 P15538 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16652179 0.80 POLB (0.66) POLBALDH1A1PKMCYP2A6MAPT
SCHEMBL1491136 0.78 POLB (0.69) POLBKDM4EALDH1A1PKMMEN1
SCHEMBL433371 0.74 POLB (1.00) POLBKDM4EALDH1A1PKMMEN1
SCHEMBL5306978 0.71 POLB (0.64) POLBKDM4EALDH1A1PKMMEN1
SCHEMBL1491089 0.71 POLB (0.64) POLBKDM4EALDH1A1MEN1MAPT
SCHEMBL4951229 0.71 POLB (0.64) POLBKDM4EALDH1A1CYP2A6MEN1
SCHEMBL1247688 0.71 POLB (0.64) POLBKDM4EALDH1A1MEN1MAPT
SCHEMBL1491115 0.71 POLB (0.64) POLBKDM4EALDH1A1MEN1MAPT
SCHEMBL23780337 0.69 HCAR2 (0.41) POLBKDM4EALDH1A1GRM1GAA
SCHEMBL15428658 0.69 POLB (0.57) POLBKDM4EALDH1A1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013004617-A1 PYRAZOLOPYRIDINES USEFUL IN THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM H. LUNDBECK A/S (DK) 2013-01-10 WO disclosed